Abstract: The present invention relates to non-transgenic and transgenic plants, preferably crop plants, comprising at least one mutation of the KINTEOCHORE NULL2 (KNL2) protein, especially a mutation causing a substitution of an amino acid within the KNL2 protein, preferably within the C-terminal region of the KNL2 protein, which preferably have the biological activity of a haploid inducer. Further, the present invention provides methods of generating the plants of the present invention and haploid and double haploid plants obtainable by crossing the plants of the present invention with wildtype plants as well as methods of facilitating cytoplasm exchange.

Abstract: The present invention relates to a method for production of an oligomeric protein in eukaryotic cells by co-expression of two fusion proteins in eukaryotic cells comprising a protein-S-Tag fusion protein, wherein the protein is an antigen or an antibody, and a S-protein-tail piece (tp) fusion protein. Furthermore the present invention relates to an oligomeric protein comprising at least a protein-S-Tag fusion protein and a S-protein-tail piece (tp) fusion protein, wherein the protein of the protein-S-Tag fusion protein is an antigen or an antibody, and the use in vaccines.

Abstract: The present invention relates to nucleic acid molecules for use in inducing apomixis in a plant, transgenic cells, in particular transgenic plant cells, comprising said nucleic acid molecule, transgenic plants, in particular plant seeds, comprising said nucleic acid molecule, methods for inducing apomixis in a plant, methods for the production of apomictic plants and uses thereof.

Abstract: The invention relates to promoter regions, under the control of which transgenes can be expressed in plants in an epidermis-specific and pathogen-inducible manner. The invention also relates to recombinant nucleic acid molecules, including the promoters, to transgenic plants and plant cells, transformed with said the nucleic acid molecules and to methods for producing the same. The invention also relates to nucleic acid molecules, including a promoter according to the invention, nucleic acid sequences or transgenes, which can convey resistance to pathogens, plants and cell plants, transformed with the nucleic acid molecules and methods for producing the same. The invention also relates to the use of the promoter region according to the invention for analyzing pathogen-induced signal transduction pathways in plant cells.

Abstract: The invention relates to methods of producing transgenic plants including pathogen resistant plants with recombinant nucleic acid molecules comprising promoter regions which provides expression of a desired transgene in epidermis-specific manner, and transgenic plants produced by said methods.

Abstract: The present invention relates to detergents comprising at least one anthocyanase (anthocyanin-?-glucosidase). The invention further relates to methods for cleaning and/or decoloring objects, in particular textiles, methods for decoloring liquids, in particular fruit juices, as well as methods for preventing precipitations in the manufacture and/or storage of anthocyanin-containing drinks, preferably red wine, where the object, liquid or drink to be treated is contacted with at least one anthocyanase (anthocyanin-?-glucosidase). The invention is also directed to the use of an anthocyanase in a detergent and/or a method of the invention.

Abstract: The invention relates to cassettes for the expression of storable gene products in leaves and specifically in seeds, especially single-chain antibody fragments in leaves and seeds of transgenic tobacco and pea plants. The fields of application of the invention are biotechnology, medicine (diagnosis and therapy), foodstuffs and plant control and agriculture. The expression cassette of the invention comprises constitutive or seed-specific promoters, the LeB4 signal peptide, a gene to be expressed and an ER retention signal. Preference is given to an expression cassette containing the CaMV 35S promoter as the constitutive promoter, the gene for a single-chain antibody fragment as the gene and the amino acid sequence KDEL as the ER retention signal.